← Leaderboards
Yang Zhou
Brown University
$3,683,712
Attributed
$5,650,606
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,650,606 · 3
By mechanism
T32$2,622,525 · 1
R01$2,175,992 · 1
P20$852,089 · 1
Top collaborators
- Elizabeth O Harrington4 shared
- Sharon Irene Smith Rounds4 shared
- Mitchell M Levy2 shared
- Corey E Ventetuolo2 shared
Most similar at Brown University
Same institution · by research overlap
- David Garcia$117,917
- Kevin C Connolly$96,668
- Elizabeth O Harrington$13,061,595
Others in their field
Other Emerging Leaders on “Phenotype”
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,463,085
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$28,580,688
- Evan Z Macosko · Broad Institute, Inc.$28,218,682
- Badri N Vardarajan · University Of Miami School Of Medicine$23,982,327
Research focus
PhenotypeRepairedMortalityMouse ModelPulmonary FibrosisReceptorLaboratoriesMediatingInjury And RepairGalectin 3ProteinsFibroblastsExperimental StudyLungApoptosisChitinaseCell InjuryFibrosisIdiopathic Pulmonary FibrosisCellsCell TypeBiologyLung DiseasesResponse
Grant awards (16)
Brown Respiratory Research Training Program$673,985
T32 · FY2025 · HL
Brown Respiratory Research Training Program$660,172
T32 · FY2024 · HL
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$406,250
R01 · FY2024 · HL · contact PI
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$88,232
R01 · FY2024 · HL · contact PI
Brown Respiratory Research Training Program$651,087
T32 · FY2023 · HL
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$406,250
R01 · FY2023 · HL · contact PI
Targeting CHI3L and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$44,732
R01 · FY2023 · HL · contact PI
Brown Respiratory Research Training Program$637,281
T32 · FY2022 · HL
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$404,293
R01 · FY2022 · HL · contact PI
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis$64,700
P20 · FY2022 · GM · contact PI
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$419,985
R01 · FY2021 · HL · contact PI
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis$53,252
P20 · FY2021 · GM · contact PI
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease$406,250
R01 · FY2020 · HL · contact PI
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis$235,237
P20 · FY2020 · GM · contact PI
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis$242,563
P20 · FY2019 · GM · contact PI
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis$256,337
P20 · FY2018 · GM · contact PI